Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: Exploratory analysis of phase III OVA-301 study

✍ Scribed by Monk, B.J.; Ghatage, P.; Parekh, T.; Henitz, E.; Knoblauch, R.; Soto Matos-Pita, A.; Nieto, A.; Park, Y.C.; Ricci, D.; Poveda, A.

• Book ID: 126849647
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 62 KB
• Volume: 133
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.03.119